269 related articles for article (PubMed ID: 30321187)
21. A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects.
Simon-Vecsei Z; Király R; Bagossi P; Tóth B; Dahlbom I; Caja S; Csosz É; Lindfors K; Sblattero D; Nemes É; Mäki M; Fésüs L; Korponay-Szabó IR
Proc Natl Acad Sci U S A; 2012 Jan; 109(2):431-6. PubMed ID: 22198767
[TBL] [Abstract][Full Text] [Related]
22. Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells.
Soluri MF; Boccafoschi F; Cotella D; Moro L; Forestieri G; Autiero I; Cavallo L; Oliva R; Griffin M; Wang Z; Santoro C; Sblattero D
FASEB J; 2019 Feb; 33(2):2327-2342. PubMed ID: 30285580
[TBL] [Abstract][Full Text] [Related]
23. Enhanced B-Cell Receptor Recognition of the Autoantigen Transglutaminase 2 by Efficient Catalytic Self-Multimerization.
Stamnaes J; Iversen R; du Pré MF; Chen X; Sollid LM
PLoS One; 2015; 10(8):e0134922. PubMed ID: 26244572
[TBL] [Abstract][Full Text] [Related]
24. Self-assembly of tissue transglutaminase into amyloid-like fibrils using physiological concentration of Ca2+.
Kalhor HR; Shahin V F; Fouani MH; Hosseinkhani H
Langmuir; 2011 Sep; 27(17):10776-84. PubMed ID: 21790128
[TBL] [Abstract][Full Text] [Related]
25. Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling.
Filiano AJ; Bailey CD; Tucholski J; Gundemir S; Johnson GV
FASEB J; 2008 Aug; 22(8):2662-75. PubMed ID: 18375543
[TBL] [Abstract][Full Text] [Related]
26. PINK1 phosphorylates transglutaminase 2 and blocks its proteasomal degradation.
Min B; Kwon YC; Choe KM; Chung KC
J Neurosci Res; 2015 May; 93(5):722-35. PubMed ID: 25557247
[TBL] [Abstract][Full Text] [Related]
27. Endoplasmic reticulum-resident protein 57 (ERp57) oxidatively inactivates human transglutaminase 2.
Yi MC; Melkonian AV; Ousey JA; Khosla C
J Biol Chem; 2018 Feb; 293(8):2640-2649. PubMed ID: 29305423
[TBL] [Abstract][Full Text] [Related]
28. Structural Basis for Antigen Recognition by Transglutaminase 2-specific Autoantibodies in Celiac Disease.
Chen X; Hnida K; Graewert MA; Andersen JT; Iversen R; Tuukkanen A; Svergun D; Sollid LM
J Biol Chem; 2015 Aug; 290(35):21365-75. PubMed ID: 26160175
[TBL] [Abstract][Full Text] [Related]
29. GTP-dependent conformational changes associated with the functional switch between Galpha and cross-linking activities in brain-derived tissue transglutaminase.
Monsonego A; Friedmann I; Shani Y; Eisenstein M; Schwartz M
J Mol Biol; 1998 Oct; 282(4):713-20. PubMed ID: 9743620
[TBL] [Abstract][Full Text] [Related]
30. A crucial sequence for transglutaminase type 2 extracellular trafficking in renal tubular epithelial cells lies in its N-terminal beta-sandwich domain.
Chou CY; Streets AJ; Watson PF; Huang L; Verderio EA; Johnson TS
J Biol Chem; 2011 Aug; 286(31):27825-35. PubMed ID: 21652693
[TBL] [Abstract][Full Text] [Related]
31. Characterization of heparin-binding site of tissue transglutaminase: its importance in cell surface targeting, matrix deposition, and cell signaling.
Wang Z; Collighan RJ; Pytel K; Rathbone DL; Li X; Griffin M
J Biol Chem; 2012 Apr; 287(16):13063-83. PubMed ID: 22298777
[TBL] [Abstract][Full Text] [Related]
32. Dermatan sulfate is a player in the transglutaminase 2 interaction network.
Wisowski G; Koźma EM; Bielecki T; Pudełko A; Olczyk K
PLoS One; 2017; 12(2):e0172263. PubMed ID: 28199387
[TBL] [Abstract][Full Text] [Related]
33. Involvement of cell surface TG2 in the aggregation of K562 cells triggered by gluten.
Feriotto G; Calza R; Bergamini CM; Griffin M; Wang Z; Beninati S; Ferretti V; Marzola E; Guerrini R; Pagnoni A; Cavazzini A; Casciano F; Mischiati C
Amino Acids; 2017 Mar; 49(3):551-565. PubMed ID: 27699491
[TBL] [Abstract][Full Text] [Related]
34. Acyl transfer mechanisms of tissue transglutaminase.
Keillor JW; Clouthier CM; Apperley KYP; Akbar A; Mulani A
Bioorg Chem; 2014 Dec; 57():186-197. PubMed ID: 25035302
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis.
Tatsukawa H; Kojima S
Cell Biol Int; 2010 Feb; 34(3):325-34. PubMed ID: 20192918
[TBL] [Abstract][Full Text] [Related]
36. Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization.
Gundemir S; Colak G; Feola J; Blouin R; Johnson GV
Biochim Biophys Acta; 2013 Jan; 1833(1):1-10. PubMed ID: 23085038
[TBL] [Abstract][Full Text] [Related]
37. Redox regulation of transglutaminase 2 activity.
Stamnaes J; Pinkas DM; Fleckenstein B; Khosla C; Sollid LM
J Biol Chem; 2010 Aug; 285(33):25402-9. PubMed ID: 20547769
[TBL] [Abstract][Full Text] [Related]
38. Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.
Martucciello S; Paolella G; Esposito C; Lepretti M; Caputo I
Cell Mol Life Sci; 2018 Nov; 75(22):4107-4124. PubMed ID: 30136165
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of allosteric regulation of transglutaminase 2 by GTP.
Begg GE; Carrington L; Stokes PH; Matthews JM; Wouters MA; Husain A; Lorand L; Iismaa SE; Graham RM
Proc Natl Acad Sci U S A; 2006 Dec; 103(52):19683-8. PubMed ID: 17179049
[TBL] [Abstract][Full Text] [Related]
40. Gα(h)/transglutaminase-2 activity is required for maximal activation of adenylylcyclase 8 in human and rat glioma cells.
Obara Y; Yanagihata Y; Abe T; Dafik L; Ishii K; Nakahata N
Cell Signal; 2013 Mar; 25(3):589-97. PubMed ID: 23200849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
